Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul;32(7):582-589.
doi: 10.1016/j.nmd.2022.03.008. Epub 2022 Mar 31.

A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy

Affiliations
Case Reports

A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy

Olimpia Musumeci et al. Neuromuscul Disord. 2022 Jul.

Abstract

Muscle Glycogenosis type 0 (GSD0B) is an extremely rare disorder first recognized in 2007 in three siblings with childhood onset and severe cardiomyopathy. Since then, a few cases with severe cardiac involvement and premature death have been reported. We describe two unrelated cases presenting with an adult-onset myopathy with no heart involvement. Clinical features were quite similar in both patients, mainly characterized by early fatigability, myalgia and muscle weakness. Muscle biopsy revealed marked glycogen depletion in nearly all myofibers. Biochemical assay demonstrated a marked reduction of Glycogen Synthase (GS) activity. Sequence analysis of GYS1 revealed two new variants: a homozygous G to C substitution in the splice donor consensus site (c.678+1G>C) in patient1 and a homozygous missense variant c.630G>C in exon 3 (p. Asp145His) in patient 2. This study describes a new phenotype of muscle GSD0B presenting with adult onset, proximal myopathy, no cardiac abnormalities and a quite benign disease course. This report highlights the importance of a systematic diagnostic approach that includes muscle morphology and enzymatic assay to facilitate the identification of adult patients with GSD0B.

Keywords: GSD0B; Metabolic myopathy; Muscle glycogenosis; Muscle morphologic studies; Muscle weakness.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All other authors report no disclosures.

Similar articles

Cited by

  • Neurological glycogen storage diseases and emerging therapeutics.
    Colpaert M, Singh PK, Donohue KJ, Pires NT, Fuller DD, Corti M, Byrne BJ, Sun RC, Vander Kooi CW, Gentry MS. Colpaert M, et al. Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14. Neurotherapeutics. 2024. PMID: 39277505 Free PMC article. Review.
  • Glycogen storage diseases.
    Hannah WB, Derks TGJ, Drumm ML, Grünert SC, Kishnani PS, Vissing J. Hannah WB, et al. Nat Rev Dis Primers. 2023 Sep 7;9(1):46. doi: 10.1038/s41572-023-00456-z. Nat Rev Dis Primers. 2023. PMID: 37679331 Review.
  • Cardiovascular involvement in glycogen storage diseases.
    Pinós T, Cubbon RM, Santalla A, Fiuza-Luces C, Santos-Lozano A, Martín MA, Arenas J, Nielsen J, Ørtenblad N, Lucia A. Pinós T, et al. Nat Rev Cardiol. 2025 Jun 5. doi: 10.1038/s41569-025-01171-w. Online ahead of print. Nat Rev Cardiol. 2025. PMID: 40473899 Review.
  • Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).
    Mishra K, Kakhlon O. Mishra K, et al. Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096. Biomolecules. 2024. PMID: 39334863 Free PMC article. Review.

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources